6th National Professional Education Program
Early Diagnosis and Early Treatment of MS: What Nurses Need To Know
The National MS Society is pleased to offer Early Diagnosis and Early Treatment of MS: What Nurses Need to Know. Developed by the Clinical Programs Department, the program is offered by the Society at locations around the country.
No programs available at this time
Program Description
Multiple sclerosis (MS) is thought to be an immune-mediated disease that primarily affects the central nervous system (CNS). Most commonly diagnosed in early adulthood, the disease is chronic, unpredictable and often debilitating. Recent MRI evidence suggests that disease activity in the CNS precedes clinical symptoms, and continues even though the disease may appear to be in remission. Nationally-recommended practice guidelines advocate early immunomodulatory treatment to slow disease progression and help prevent irreversible neurologic damage.
By educating patients about the disease-modifying therapies and helping to manage the side effects that often accompany these agents, nurses play an important role in helping people with MS to formulate realistic therapeutic expectations and adhere to a treatment regimen.
Agenda
- Welcome and Introductions
- Video presentation featuring:
Aliza Ben-Zacharia, ANP-C, Nurse Practitioner
Fred D. Lublin, MD, Director
Corrine Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai Medical Center, New York, New York - Moderated discussion/Q&A
- Adjournment
Program Format
This educational program consists of a video presentation followed by locally-moderated discussion and Q&A.
Learning Objectives
Upon completion of this program, nurses will be able to:
- Describe the current guidelines used to establish a diagnosis of MS
- Explain the importance of early treatment with disease-modifying therapies
- List strategies to help patients adhere to disease-modifying therapies
Registration Fees and Cancellation Policy
$25 in advance; $30 on site. Registration cancellation refunds (less $10 processing fee) must be requested in writing no later than 5 business days prior to the meeting. No-shows will not receive a refund. Consult your local chapter for more information.
Accreditation
The University of Texas at Arlington is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This activity meets the Type 1 criteria for mandatory continuing education requirements toward re-licensure as established by the Board of Nurse Examiners for the State of Texas. This activity provides 1.2 contact hours.
The National Multiple Sclerosis Society, Northern California Chapter is the CE provider for this program in California. Provider approved by the California Board of Registered Nursing, Provider Number CEP7922 for 1.2 contact hours.